Navigation Links
Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders
Date:11/11/2011

sions.  As a specialty pharmaceutical company, Bayer HealthCare provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women's Healthcare.  The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Forward-looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

(1) http://www.cdc.gov/ncbddd/hemophilia/data.html

BAYER and the Bayer Cross are registered trademarks of Bayer.  

KN28000611


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced positive results from a randomized, double-blind ... CCH) for the treatment of edematous fibrosclerotic panniculopathy ... 2a trial, all three doses of CCH (low ... improvement in the appearance of cellulite as measured ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... of Advanced Medical Center, Licensed to ... Administer PROMETA(R), ... use, Dr. Gregory Ellison, Director of Advanced Medical,Center, has identified a ... is performed on an out-patient (versus,in-patient) basis in 10 hours over ...
... Upcoming ECCMID Conference, REINACH, Switzerland, April 11 ... April, Arpida Ltd. (SWX: ARPN) today,elaborates on some ... in complicated Skin and Skin Structure Infections,(cSSSI). Extensive ... year,s ICAAC,and IDSA meetings. Data on ASSIST-2 will ...
Cached Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
(Date:8/21/2014)... Not only is eating better and exercising healthy for people ... a year, a new study finds. The study, led ... Wake Forest Baptist Medical Center in Winston-Salem, N.C., included ... Participants ranged in age from 45 to ... change program" focused on diet and exercise, or to a ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, ... antidepressants appears to best help people with severe but ... of five people suffering from severe depression for less ... cognitive therapy plus antidepressant medication, researchers found. On ... than drugs alone in helping people with mild depression ...
(Date:8/21/2014)... A new study published this week in ... associated with speech problems from 2001-02 to 2010-11 among ... in disability associated with hearing problems. The data underscore ... children who are experiencing communication disorders, according to the ... a broader level, the new study, Changing Trends ...
(Date:8/21/2014)... in rural communities do not routinely screen women ... State medical and public health researchers. Rural women ... resources if they seek help., "Rural health care ... Jennifer S. McCall-Hosenfeld, a primary care physician and ... Penn State College of Medicine. "However, in rural ...
(Date:8/21/2014)... York (PRWEB) August 21, 2014 Xarelto ... thinner caused patients to suffer uncontrollable internal bleeding and ... Bernstein Liebhard LLP reports. According to court documents, a ... U.S. District Court, Easter District of New York by ... to a bleeding event that was allegedly caused by ...
Breaking Medicine News(10 mins):Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 3Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 4
... With ... Disabilities, CHICAGO, ... its 27th annual ,Cones for Kids, Valentine,s Day,fundraiser to benefit Easter ... just over $616,000 to help,children and adults with disabilities in 16 ...
... and Company,(NYSE: LLY ) today announced that ... FORSTEO(R) (teriparatide [rDNA origin] injection) for the,treatment of ... and men at increased risk for fracture.,This approval ... by,the Committee for Medicinal Products for Human Use ...
... Milestone Coincides with Visit from Legendary Recording Artist ... The California Science,Center welcomed the 1-millionth visitor ... in what has been a record-breaking run for ... Exposition Park. Grammy,Award-winning recording artist Chaka Khan and ...
... aftereffects reverberate long after the incidents , , THURSDAY, April ... male partner violence suffer a wide range of physical ... study that included 25,000 women in 11 countries. , ... Brazil, Ethiopia, Japan, Namibia, Peru, Samoa, Serbia and Montenegro, ...
... is,pleased to join Harvard University,s Ash Institute for ... bi-annual conference,Frontiers of Innovation: 20 Years of Innovation ... On Monday evening, the executive,director of the Pan ... discussed multisector partnerships in tackling neglected,diseases and in ...
... -- time between births can be risky, research suggests , , THURSDAY, ... When is the right time to have your first child? , ... when to have the next baby -- if you decide to ... say, can decrease your risk of having a baby born premature ...
Cached Medicine News:Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:When It Comes to Pregnancy, Timing Is Everything 2Health News:When It Comes to Pregnancy, Timing Is Everything 3
... Viscoelastic System is designed to give two ... can be used differently and sequentially to ... The choice of the viscoelastic is based ... of each to facilitate performance of the ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... and the FF 450plus Fundus Camera are ... of accuracy and security that can't be ... Without this level of integrated synergy, calibration ... VISUPAC system pixel for pixel, the FF ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
Medicine Products: